SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 141 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,000 | -66.7% | 2,064 | -50.4% | 0.00% | – |
Q2 2022 | $3,000 | -84.2% | 4,160 | -71.8% | 0.00% | – |
Q1 2022 | $19,000 | -88.6% | 14,777 | -88.7% | 0.00% | – |
Q4 2021 | $166,000 | -85.6% | 130,359 | -75.3% | 0.00% | -100.0% |
Q3 2021 | $1,150,000 | -52.8% | 527,434 | -18.7% | 0.00% | 0.0% |
Q2 2021 | $2,434,000 | +2.1% | 648,990 | -11.3% | 0.00% | -50.0% |
Q1 2021 | $2,385,000 | +1196.2% | 731,629 | +1253.6% | 0.00% | – |
Q4 2020 | $184,000 | +178.8% | 54,052 | +230.7% | 0.00% | – |
Q3 2020 | $66,000 | -82.3% | 16,345 | -85.2% | 0.00% | – |
Q2 2020 | $373,000 | +103.8% | 110,465 | +41.3% | 0.00% | – |
Q1 2020 | $183,000 | -18.3% | 78,164 | +27.1% | 0.00% | – |
Q4 2019 | $224,000 | -88.0% | 61,475 | -72.7% | 0.00% | -100.0% |
Q3 2019 | $1,870,000 | +72.8% | 225,471 | +79.3% | 0.00% | 0.0% |
Q2 2019 | $1,082,000 | +51.1% | 125,739 | +87.8% | 0.00% | 0.0% |
Q1 2019 | $716,000 | -84.1% | 66,968 | -87.0% | 0.00% | -75.0% |
Q4 2018 | $4,492,000 | +254.0% | 513,317 | +578.9% | 0.00% | +300.0% |
Q3 2018 | $1,269,000 | -74.9% | 75,613 | -68.6% | 0.00% | -75.0% |
Q2 2018 | $5,050,000 | +138.8% | 240,903 | +83.4% | 0.00% | +100.0% |
Q1 2018 | $2,115,000 | -41.3% | 131,375 | -30.9% | 0.00% | -33.3% |
Q4 2017 | $3,605,000 | +132.1% | 190,192 | +72.3% | 0.00% | +200.0% |
Q3 2017 | $1,553,000 | +53.9% | 110,367 | -18.5% | 0.00% | 0.0% |
Q2 2017 | $1,009,000 | +70.4% | 135,421 | +48.6% | 0.00% | 0.0% |
Q1 2017 | $592,000 | +13.6% | 91,134 | -22.4% | 0.00% | – |
Q4 2016 | $521,000 | +41.6% | 117,417 | +49.3% | 0.00% | – |
Q3 2016 | $368,000 | +72.0% | 78,642 | +140.7% | 0.00% | – |
Q2 2016 | $214,000 | -36.7% | 32,666 | -38.5% | 0.00% | – |
Q1 2016 | $338,000 | +454.1% | 53,104 | +426.4% | 0.00% | – |
Q4 2015 | $61,000 | -80.2% | 10,089 | -80.4% | 0.00% | – |
Q3 2015 | $308,000 | +584.4% | 51,398 | +682.6% | 0.00% | – |
Q2 2015 | $45,000 | +21.6% | 6,568 | +6.8% | 0.00% | – |
Q1 2015 | $37,000 | -71.1% | 6,149 | -66.7% | 0.00% | – |
Q4 2014 | $128,000 | +120.7% | 18,491 | +160.7% | 0.00% | – |
Q3 2014 | $58,000 | -33.3% | 7,093 | -34.1% | 0.00% | – |
Q2 2014 | $87,000 | -50.6% | 10,762 | -51.9% | 0.00% | – |
Q1 2014 | $176,000 | -64.0% | 22,392 | -59.5% | 0.00% | – |
Q4 2013 | $489,000 | +97.2% | 55,309 | +87.1% | 0.00% | – |
Q3 2013 | $248,000 | -3.9% | 29,560 | -14.5% | 0.00% | – |
Q2 2013 | $258,000 | – | 34,554 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |